General Information of the Compound
| Compound ID |
CP0396286
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(3R,5S)-N-benzyl-3,5-dimethyl-1-[[6-(trifluoromethyl)pyridin-2-yl]methyl]-3,5-dihydro-2H-1,4-benzodiazepine-4-carboxamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C26H27F3N4O
|
||||||||||||||||||
| Molecular Weight |
468.523
|
||||||||||||||||||
| Canonical SMILES |
C[C@@H]1CN(Cc2cccc(n2)C(F)(F)F)c2ccccc2[C@H](C)N1C(=O)NCc1ccccc1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C26H27F3N4O/c1-18-16-32(17-21-11-8-14-24(31-21)26(27,28)29)23-13-7-6-12-22(23)19(2)33(18)25(34)30-15-20-9-4-3-5-10-20/h3-14,18-19H,15-17H2,1-2H3,(H,30,34)/t18-,19+/m1/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
UGDSBZQVPBHJIZ-MOPGFXCFSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT03095, Voltage-dependent T-type calcium channel subunit alpha-1G
Protein ID: PT04557, Voltage-dependent T-type calcium channel subunit alpha-1H
Protein ID: PT02881, Voltage-dependent T-type calcium channel subunit alpha-1I